Entero Therapeutics Subsidiary ImmunogenX, LLC Settles Legal Dispute with $7.9 Million Settlement Agreement

Reuters
15 May
Entero <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Subsidiary ImmunogenX, LLC Settles Legal Dispute with $7.9 Million Settlement Agreement

Entero Therapeutics Inc.'s wholly-owned subsidiary, ImmunogenX, LLC, has recently entered into a notable settlement agreement with Mattress Liquidators Inc., Jack A. Syage, and The Jack A. Syage and Elizabeth T. Syage Revocable Trust. As part of the agreement, the Guarantors have committed to pay $5,500,000 towards settling obligations amounting to approximately $7.9 million owed to the Plaintiff. This payment was completed on April 9, 2025. The agreement also involves the release of Mattress Liquidators Inc.'s security interest in ImmunogenX, LLC. Additionally, both parties have agreed to execute a Stipulation of Dismissal with Prejudice, which will be filed with the District Court in Boulder County, Colorado. This development marks a significant step for ImmunogenX, LLC in resolving its financial obligations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entero Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-048544), on May 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10